论文部分内容阅读
目的:探讨应用不同的药物和方法保守治疗宫外孕的临床疗效及安全性。方法:选取2007年7月至2012年6月间我院收治的宫外孕患者85例作为研究对象,并将其随机分为对照组(42例)和治疗组(43例)。为治疗组的43例患者应用顿服米非司酮联合静脉滴注甲氨蝶呤的方法进行治疗,为对照组的42例患者应用肌肉注射甲氨蝶呤的方法进行治疗,将两组患者的临床疗效及不良反应发生率进行对比,并将其临床资料进行回顾性的分析。结果:治疗组患者的治疗总有效率为95.23%,对照组患者的治疗总有效率为81.39%,治疗组患者的治疗总有效率明显优于对照组患者,差异较显著(P<0.05),具有统计学意义;治疗组患者的不良反应发生率为47.62%(主要表现为胃肠道不适、腹痛等症状),对照组患者的不良反应发生率为79.07%(主要表现为胃肠道不适、腹痛、口腔溃疡及肝功能受损等症状),治疗组患者的不良反应发生率明显低于对照组患者,差异较显著(P<0.05),具有统计学意义。结论:应用顿服米非司酮联合静脉滴注甲氨蝶呤的方法治疗宫外孕的临床疗效显著,还可以降低不良反应的发生率,值得在临床上推广应用。
Objective: To explore the clinical efficacy and safety of conservative treatment of ectopic pregnancy with different drugs and methods. Methods: Totally 85 patients with ectopic pregnancy admitted to our hospital from July 2007 to June 2012 were selected as study subjects and randomly divided into control group (n = 42) and treatment group (n = 43). For the treatment group, 43 patients treated with Dayton mifepristone combined with intravenous methotrexate treatment for the control group, 42 patients were treated with intramuscular methotrexate treatment, the two groups of patients The clinical efficacy and incidence of adverse reactions were compared, and its clinical data were retrospectively analyzed. Results: The total effective rate was 95.23% in the treatment group and 81.39% in the control group. The total effective rate of the treatment group was significantly higher than that of the control group (P <0.05) The incidence of adverse reactions in the treatment group was 47.62% (mainly gastrointestinal discomfort, abdominal pain and other symptoms), the incidence of adverse reactions in the control group was 79.07% (mainly gastrointestinal discomfort, Abdominal pain, oral ulcer and impaired liver function). The incidence of adverse reactions in the treatment group was significantly lower than that in the control group (P <0.05), which was statistically significant. Conclusion: The application of Dayun mifepristone combined with intravenous methotrexate in the treatment of ectopic pregnancy significant clinical effect, but also can reduce the incidence of adverse reactions, it is worth to promote the clinical application.